NCT01650220

Brief Summary

This is an observational study designed to determine whether veterans with PTSD have a higher risk of heart disease than those without PTSD. Cardiovascular risk will be assessed by interview and review of medical records, carotid artery ultrasound, and blood tests measuring markers of inflammation. Study participation is approximately 6 months. The eligible study population is veterans of Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF), age 28 through 38 years.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2012

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2012

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 20, 2012

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 26, 2012

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2013

Completed
Last Updated

April 29, 2013

Status Verified

April 1, 2013

Enrollment Period

9 months

First QC Date

June 20, 2012

Last Update Submit

April 25, 2013

Conditions

Outcome Measures

Primary Outcomes (5)

  • Recruitment methods feasibility

    Comparison of the number of participants per month recruited from medical providers (with/without PTSD) vs. response to recruitment fliers (with/without PTSD) in the first 12 months of the study. Selection bias to be determined by looking at differences in age and co-morbid illnesses.

    12 months

  • Completion of structured diagnostic interview within 2hrs.

    Completion of Clinician Assessed PTSD Scale (CAPS), Alcohol Use Disorders Identification Test-Consumption (AUDIT-C), Patient Health Questionnaire-9 (PHQ-9), Pittsburgh Sleep Quality Index (PSQI), INTRuST Uniformed Data Set, and Family History of heart disease, within 2hrs.

    12 months

  • Ability to schedule Carotid Intima-Media Thickness (CIMT) ultrasound in the Vascular Lab at VA San Diego Healthcare Systems, within 4 months of enrollment

    Determining whether the Vascular Lab has the capacity for a larger clinical study will be informative in planning larger prospective studies.

    18months

  • Time from CIMT completion to completion of clinical read.

    Rate of clinical read will help in determining adequate staffing requirements for a larger study.

    18months

  • Completion of serum lab measurements.

    18months

Secondary Outcomes (2)

  • Carotid Intimal Medial Thickness (CIMT) measurement

    Within 4 months of subject recruitment

  • Cardiovascular Disease Biomarkers

    Within 6 months of subject recruitment

Study Arms (2)

Veterans with a history of PTSD

Veterans without a history of PTSD

Eligibility Criteria

Age28 Years - 38 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

OIF and OEF veterans within the VASDHS, who are between 28 and 38 years of age inclusively

You may qualify if:

  • OEF/OIF veterans at the VASDHS
  • Between 28 and 38 years of age
  • Willing to complete structured diagnostic interview for PTSD, CIMT ultrasound and blood test
  • Willing to have a review of their medical records
  • Able to give informed consent
  • Have a negative urine pregnancy test, if a woman of child-bearing age

You may not qualify if:

  • History of schizophrenia, other neurocognitive illness (including severe TBI by INTRuST criteria)) or active alcohol and/or drug abuse determined by chart review, interview or AUDIT-C score
  • Inability to complete study tests within 18 months of study start
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VASDHS

San Diego, California, 92161, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

For the assessment of CVD risk, high-sensitivity CRP (hs-CRP) measurements will be used. Standard assays detect 1,000 fold increases in CRP in response to infection or inflammation; these high levels cannot be used to stratify with respect to CVD risk. Hs-CRP, however, measurement can detect CRP levels as low as 0.5 mg/L. Though mainly used for research purposes, high-sensitivity IL-6 assays are also able to discriminate IL-6 levels within the normal range for CVD risk stratification. Both CRP and IL-6 levels will be analyzed as continuous quantitative traits. Though no DNA analysis is planned for this study, subjects are asked if they are willing to have their samples banked for future research.

MeSH Terms

Conditions

Cardiovascular DiseasesStress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Vibha Bhatnagar, MD

    University of California, San Diego

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 20, 2012

First Posted

July 26, 2012

Study Start

April 1, 2012

Primary Completion

January 1, 2013

Study Completion

January 1, 2013

Last Updated

April 29, 2013

Record last verified: 2013-04

Locations